Showing results (651-660 of 14,699) with videos related to

Sort By:
Pageof 1,470
Pharmaceutics|July 20, 2018
Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1Yongtao Tong, Yuli Wang, Meiyan Yang, et al.
Pharmaceutics|September 7, 2016
An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot SystemsDileep R Janagam, Lizhu Wang, Suryatheja Ananthula, et al.
Pharmaceutics|May 26, 2018
Magnetic Nanoparticles Conjugated with Peptides Derived from Monocyte Chemoattractant Protein-1 as a Tool for Targeting AtherosclerosisChung-Wei Kao, Po-Ting Wu, Mei-Yi Liao, et al.
Pharmaceutics|May 23, 2018
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier SystemsM Danaei, M Dehghankhold, S Ataei, et al.
Pharmaceutics|July 1, 2018
Loading IR820 Using Multifunctional Dendrimers with Enhanced Stability and SpecificityHui Liu, Jingjing Wang
Pharmaceutics|July 5, 2018
Synthesis, Structure⁻Activity Relationships and In Vitro Toxicity Profile of Lactose-Based Fatty Acid Monoesters as Possible Drug Permeability EnhancersSimone Lucarini, Laura Fagioli, Robert Cavanagh, et al.
Pharmaceutics|July 11, 2018
Bioavailability Enhancement of Poorly Water-Soluble Drugs via Nanocomposites: Formulation⁻Processing Aspects and ChallengesAnagha Bhakay, Mahbubur Rahman, Rajesh N Dave, et al.
Pharmaceutics|July 11, 2018
Oral Bioavailability of Kinsenoside in Beagle Dogs Measured by LC-MS/MS: Improvement of Ex Vivo Stability of a Lactone-Containing CompoundXin Zhang, Ming Jin, Yuping Liu, et al.
Pharmaceutics|July 14, 2018
Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass SpectrometryJae-Kyung Heo, Hyun-Ji Kim, Ga-Hyun Lee, et al.
Pharmaceutics|June 9, 2018
A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model MouseSeok-Ho Shin, Min-Ho Park, Jin-Ju Byeon, et al.
Pageof 1,470